Mizuho Maintains Outperform on Guardant Health, Raises Price Target to $200

Benzinga · 2d ago
Mizuho analyst Anthony Petrone maintains Guardant Health (NASDAQ:GH) with a Outperform and raises the price target from $175 to $200.